Example: Heart Attack
Search clinical trials for: Girls Can...Move!
Total 6084 results
-
NCT02542852Completed
-
NCT04384133UnknownCOPD | Small Airway Disease
-
NCT01501708UnknownLeukemia | Transplantation, Hematopoietic Stem Cell
-
NCT04811014RecruitingSubstance Use Disorders | Opioid Dependence | Opioid Use | Opioid-use Disorder | Opioid Overdose
-
NCT06114030RecruitingCaries,Dental | Survival, Prosthesis | Failure, Prosthesis | Broken Teeth | Crown of Tooth With Poor Contour
-
NCT05185947CompletedBreast Cancer | Gynecologic Cancer | Colorectal Neoplasms | Colorectal Cancer | Ovarian Neoplasms | Peritoneal Neoplasms | Ovarian Cancer | Cholangiocarcinoma | Peritoneal Carcinomatosis | Appendiceal Neoplasms
-
NCT06340932CompletedPost Operative Pain | ACL Tear
-
NCT01088529Completed
-
-
NCT06860815RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Metastatic Carcinoma in the Liver
-
NCT06834126RecruitingStage III Rectal Cancer AJCC v8 | Locally Advanced Rectal Adenocarcinoma | Stage II Rectal Cancer AJCC v8
-
NCT06572423RecruitingRecurrent Head and Neck Carcinoma | Head and Neck Carcinoma | Metastatic Head and Neck Carcinoma | Localized Head and Neck Carcinoma
-
NCT06026657RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma
-
NCT03028311Active, not recruitingStage IV Liver Cancer | Stage IVA Liver Cancer | Stage IVB Liver Cancer | Metastatic Liver Carcinoma
-
NCT06914999RecruitingHead and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
-
NCT03941730Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Advanced Triple-Negative Breast Carcinoma
-
NCT06056895Active, not recruitingMerkel Cell Carcinoma | Clinical Stage IV Merkel Cell Carcinoma AJCC v8 | Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
-
NCT06590558WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma | Locally Advanced HER2-Negative Breast Carcinoma
-
NCT04119024RecruitingBreast Cancer | Neuroendocrine Tumors | Lung Adenocarcinoma | Metastatic Melanoma | Head and Neck Squamous Cell Carcinoma | Refractory Malignant Solid Neoplasm | Thyroid Cancer | Pheochromocytoma | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
-
-
NCT06731465Enrolling by invitationCrowding of Anterior Mandibular Teeth
-
NCT06808750CompletedSchistosoma Haematobium
-
NCT04387227Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma
-
NCT03684213CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Vasoconstriction
-
NCT05797948Enrolling by invitationRelapsed or Refractory B-cell Non-Hodgkin Lymphoma
-
NCT01692197Completed
-
NCT01927757TerminatedModerate to Severe Rheumatoid Arthritis
-
NCT07276360RecruitingCervical Cancer | Cervix Cancer | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Small Cell Carcinoma
-
NCT06959641RecruitingMetastatic Differentiated Thyroid Gland Carcinoma | Refractory Differentiated Thyroid Gland Carcinoma | Stage III Differentiated Thyroid Gland Carcinoma AJCC v8 | Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 | Metastatic Thyroid Gland Follicular Carcinoma | Metastatic Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Metastatic Thyroid Gland Oncocytic Carcinoma | Locally Advanced Differentiated Thyroid Gland Carcinoma
-
NCT06911008RecruitingRefractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
-
-
NCT06675123RecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma
-
NCT06442475RecruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal Zone Lymphoma | Ann Arbor Stage IV Marginal Zone Lymphoma
-
NCT07340853SuspendedMultiple Myeloma | Refractory Multiple Myeloma | Recurrent Multiple Myeloma
-
NCT05870761Active, not recruitingRecurrent Endometrial Serous Adenocarcinoma
-
NCT03513952CompletedAdvanced Bladder Urothelial Carcinoma | Advanced Ureter Urothelial Carcinoma | Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent Ureter Urothelial Carcinoma
-
NCT07225985RecruitingRefractory T-Cell Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma
-
NCT07150546RecruitingUnresectable Digestive System Neuroendocrine Neoplasm | Unresectable Digestive System Neuroendocrine Tumor G1 | Digestive System Neuroendocrine Tumor | Unresectable Digestive System Neuroendocrine Tumor G2
-
NCT06948084Not yet recruitingRefractory Multiple Myeloma | Recurrent Multiple Myeloma
-
NCT06532279RecruitingStomatitis | Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma
-
NCT05058651RecruitingAdvanced Extrapulmonary Neuroendocrine Carcinoma | Metastatic Extrapulmonary Neuroendocrine Carcinoma | Recurrent Extrapulmonary Neuroendocrine Carcinoma | Unresectable Extrapulmonary Neuroendocrine Carcinoma
-
NCT01167712Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma
-
NCT01886872Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia
-
NCT06624644RecruitingUnresectable Melanoma | Cutaneous Melanoma | Melanoma (Skin Cancer) | Melanoma Stage IIIB-IV
-
NCT04193878TerminatedPneumonia | COVID-19 Pneumonia | Hypoxemia | Acute Respiratory Failure
-
NCT05935774WithdrawnMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell Carcinoma
-
NCT05484401CompletedStomatognathic Diseases | Tooth Diseases | Tooth, Impacted
-
NCT00201812Completed